TARS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Tarsus Pharmaceuticals Inc (TARS).


$2.12B Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

TARS Market Cap. (MRY)


TARS Shares Outstanding (MRY)


TARS Assets (MRY)


Total Assets

$376.99M

Total Liabilities

$152.46M

Total Investments

$202.12M

TARS Income (MRY)


Revenue

$182.95M

Net Income

-$115.55M

Operating Expense

$290.70M

TARS Cash Flow (MRY)


CF Operations

-$83.03M

CF Investing

-$199.19M

CF Financing

$154.66M

TARS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TARS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$376,991,000 (42.00%)

$265,491,000 (16.51%)

$227,863,000 (27.36%)

$178,907,000 (4.03%)

Assets Current

$356,705,000 (39.27%)

$256,131,000 (13.65%)

$225,375,000 (28.09%)

$175,952,000 (3.10%)

Assets Non-Current

$20,286,000 (116.73%)

$9,360,000 (276.21%)

$2,488,000 (-15.80%)

$2,955,000 (124.37%)

Goodwill & Intangible Assets

$8,326,000 (115.31%)

$3,867,000 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$224,534,000 (13.98%)

$196,988,000 (2.12%)

$192,900,000 (15.70%)

$166,730,000 (0.45%)

Property Plant & Equipment Net

$2,866,000 (-14.40%)

$3,348,000 (118.54%)

$1,532,000 (-16.24%)

$1,829,000 (47.98%)

Cash & Equivalents

$94,819,000 (-57.85%)

$224,947,000 (213.91%)

$71,660,000 (-58.17%)

$171,332,000 (1.89%)

Accumulated Other Comprehensive Income

$179,000 (9050.00%)

-$2,000 (97.30%)

-$74,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$202,119,000 (6365.74%)

$3,126,000 (-97.86%)

$145,737,000 (30073.29%)

$483,000 (0%)

Investments Current

$196,557,000 (7778.04%)

$2,495,000 (-98.28%)

$145,366,000 (29996.48%)

$483,000 (0%)

Investments Non-Current

$5,562,000 (781.46%)

$631,000 (70.08%)

$371,000 (0%)

$0 (0%)

Inventory

$5,153,000 (65.85%)

$3,107,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$48,059,000 (171.31%)

$17,714,000 (394.53%)

$3,582,000 (3793.48%)

$92,000 (360.00%)

Trade & Non-Trade Payables

$64,789,000 (173.48%)

$23,691,000 (139.06%)

$9,910,000 (14.17%)

$8,680,000 (99.68%)

Accumulated Retained Earnings (Deficit)

-$360,210,000 (-47.23%)

-$244,656,000 (-124.94%)

-$108,763,000 (-133.04%)

-$46,672,000 (-42.10%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$71,845,000 (140.94%)

$29,819,000 (53.44%)

$19,434,000 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$71,845,000 (140.94%)

$29,819,000 (53.44%)

$19,434,000 (0%)

$0 (0%)

Total Liabilities

$152,457,000 (122.56%)

$68,503,000 (95.93%)

$34,963,000 (187.12%)

$12,177,000 (103.22%)

Liabilities Current

$80,612,000 (118.25%)

$36,936,000 (139.39%)

$15,429,000 (34.42%)

$11,478,000 (113.07%)

Liabilities Non-Current

$71,845,000 (127.60%)

$31,567,000 (61.60%)

$19,534,000 (2694.56%)

$699,000 (15.54%)

TARS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$182,953,000 (948.62%)

$17,447,000 (-32.42%)

$25,816,000 (-54.73%)

$57,027,000 (0%)

Cost of Revenue

$12,826,000 (705.15%)

$1,593,000 (66.81%)

$955,000 (-53.98%)

$2,075,000 (0%)

Selling General & Administrative Expense

$237,310,000 (118.32%)

$108,700,000 (141.83%)

$44,949,000 (76.99%)

$25,397,000 (210.78%)

Research & Development Expense

$53,386,000 (6.11%)

$50,312,000 (18.04%)

$42,624,000 (2.19%)

$41,712,000 (121.57%)

Operating Expenses

$290,696,000 (82.81%)

$159,012,000 (81.58%)

$87,573,000 (30.49%)

$67,109,000 (148.57%)

Interest Expense

$7,849,000 (134.58%)

$3,346,000 (52.16%)

$2,199,000 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

-$4,000 (-107.27%)

$55,000 (5400.00%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$115,554,000 (14.97%)

-$135,893,000 (-118.86%)

-$62,091,000 (-349.06%)

-$13,827,000 (48.43%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$115,554,000 (14.97%)

-$135,893,000 (-118.86%)

-$62,091,000 (-349.06%)

-$13,827,000 (48.43%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$115,554,000 (14.97%)

-$135,893,000 (-118.86%)

-$62,091,000 (-349.06%)

-$13,827,000 (48.43%)

Weighted Average Shares

$37,604,538 (27.98%)

$29,383,276 (19.35%)

$24,619,700 (19.78%)

$20,554,086 (231.12%)

Weighted Average Shares Diluted

$37,604,538 (27.98%)

$29,383,276 (19.35%)

$24,619,700 (19.78%)

$20,554,086 (231.12%)

Earning Before Interest & Taxes (EBIT)

-$107,705,000 (18.74%)

-$132,547,000 (-121.30%)

-$59,896,000 (-334.91%)

-$13,772,000 (48.63%)

Gross Profit

$170,127,000 (973.09%)

$15,854,000 (-36.23%)

$24,861,000 (-54.76%)

$54,952,000 (0%)

Operating Income

-$120,569,000 (15.78%)

-$143,158,000 (-128.28%)

-$62,712,000 (-415.85%)

-$12,157,000 (54.97%)

TARS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$199,195,000 (-241.67%)

$140,604,000 (197.22%)

-$144,629,000 (-24580.72%)

-$586,000 (-28.51%)

Net Cash Flow from Financing

$154,656,000 (18.81%)

$130,176,000 (38.50%)

$93,987,000 (447457.14%)

$21,000 (-99.98%)

Net Cash Flow from Operations

-$83,027,000 (29.33%)

-$117,493,000 (-139.63%)

-$49,030,000 (-1408.16%)

$3,748,000 (117.73%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$127,566,000 (-183.22%)

$153,287,000 (253.79%)

-$99,672,000 (-3231.39%)

$3,183,000 (-97.11%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$192,628,000 (-231.84%)

$146,106,000 (201.38%)

-$144,123,000 (0%)

$0 (0%)

Capital Expenditure

-$6,567,000 (-19.36%)

-$5,502,000 (-987.35%)

-$506,000 (13.65%)

-$586,000 (-28.51%)

Issuance (Repayment) of Debt Securities

$39,600,000 (296.00%)

$10,000,000 (-47.71%)

$19,125,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$115,056,000 (-4.26%)

$120,176,000 (60.37%)

$74,937,000 (23028.70%)

$324,000 (-99.65%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$27,818,000 (40.28%)

$19,830,000 (47.33%)

$13,460,000 (59.20%)

$8,455,000 (907.75%)

Depreciation Amortization & Accretion

$1,860,000 (31.17%)

$1,418,000 (79.72%)

$789,000 (30.20%)

$606,000 (146.34%)

TARS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

93.00% (2.31%)

90.90% (-5.61%)

96.30% (-0.10%)

96.40%

Profit Margin

-63.20% (91.89%)

-778.90% (-223.87%)

-240.50% (-893.80%)

-24.20%

EBITDA Margin

-57.90% (92.30%)

-751.60% (-228.21%)

-229.00% (-891.34%)

-23.10%

Return on Average Equity (ROAE)

-46.70% (37.15%)

-74.30% (-129.32%)

-32.40% (-320.78%)

-7.70% (77.01%)

Return on Average Assets (ROAA)

-31.20% (46.39%)

-58.20% (-110.87%)

-27.60% (-283.33%)

-7.20% (69.10%)

Return on Sales (ROS)

-58.90% (92.25%)

-759.70% (-227.46%)

-232.00% (-862.66%)

-24.10%

Return on Invested Capital (ROIC)

-52.90% (67.86%)

-164.60% (-78.91%)

-92.00% (39.47%)

-152.00% (-105.78%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-18.04 (-311.50%)

-4.38 (24.65%)

-5.82 (82.68%)

-33.58 (-251.02%)

Price to Sales Ratio (P/S)

11.38 (-66.63%)

34.1 (143.93%)

13.98 (72.39%)

8.11

Price to Book Ratio (P/B)

9.43 (177.02%)

3.4 (67.88%)

2.03 (-27.35%)

2.79 (-44.86%)

Debt to Equity Ratio (D/E)

0.68 (95.11%)

0.35 (92.27%)

0.18 (147.95%)

0.07 (102.78%)

Earnings Per Share (EPS)

-3.07 (33.55%)

-4.62 (-83.33%)

-2.52 (-276.12%)

-0.67 (84.49%)

Sales Per Share (SPS)

4.87 (719.02%)

0.59 (-43.37%)

1.05 (-62.18%)

2.77 (0%)

Free Cash Flow Per Share (FCFPS)

-2.38 (43.07%)

-4.19 (-108.05%)

-2.01 (-1406.49%)

0.15 (104.43%)

Book Value Per Share (BVPS)

5.97 (-10.93%)

6.7 (-14.44%)

7.83 (-3.41%)

8.11 (-69.66%)

Tangible Assets Book Value Per Share (TABVPS)

9.8 (10.11%)

8.9 (-3.79%)

9.26 (6.33%)

8.7 (-68.58%)

Enterprise Value Over EBIT (EV/EBIT)

-19 (-375.00%)

-4 (0.00%)

-4 (80.00%)

-20 (28.57%)

Enterprise Value Over EBITDA (EV/EBITDA)

-19.01 (-426.59%)

-3.61 (11.41%)

-4.08 (80.94%)

-21.38 (24.64%)

Asset Turnover

0.49 (560.00%)

0.07 (-34.78%)

0.12 (-61.41%)

0.3 (0%)

Current Ratio

4.42 (-36.18%)

6.93 (-52.53%)

14.61 (-4.71%)

15.33 (-51.61%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$89,594,000 (27.16%)

-$122,995,000 (-148.29%)

-$49,536,000 (-1666.60%)

$3,162,000 (114.64%)

Enterprise Value (EV)

$2,012,123,059 (325.03%)

$473,404,393 (96.53%)

$240,881,276 (-14.41%)

$281,431,320 (-62.65%)

Earnings Before Tax (EBT)

-$115,554,000 (14.97%)

-$135,893,000 (-118.85%)

-$62,095,000 (-350.88%)

-$13,772,000 (48.63%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$105,845,000 (19.28%)

-$131,129,000 (-121.85%)

-$59,107,000 (-348.94%)

-$13,166,000 (50.44%)

Invested Capital

$265,079,000 (796.75%)

$29,560,000 (-81.55%)

$160,208,000 (4204.74%)

-$3,903,000 (-149.55%)

Working Capital

$276,093,000 (25.96%)

$219,195,000 (4.41%)

$209,946,000 (27.65%)

$164,474,000 (-0.48%)

Tangible Asset Value

$368,665,000 (40.91%)

$261,624,000 (14.82%)

$227,863,000 (27.36%)

$178,907,000 (4.03%)

Market Capitalization

$2,116,625,059 (215.74%)

$670,368,393 (71.44%)

$391,014,276 (-15.95%)

$465,232,320 (-44.60%)

Average Equity

$247,368,750 (35.21%)

$182,946,250 (-4.50%)

$191,557,250 (6.19%)

$180,393,750 (125.53%)

Average Assets

$369,853,250 (58.40%)

$233,491,000 (3.93%)

$224,659,750 (17.21%)

$191,680,750 (66.47%)

Invested Capital Average

$203,435,500 (152.57%)

$80,546,250 (23.77%)

$65,079,750 (618.32%)

$9,060,000 (988.67%)

Shares

38,226,929 (15.47%)

33,104,612 (24.12%)

26,672,188 (28.99%)

20,676,992 (1.75%)